INIS
animals
12%
asia
17%
breasts
17%
cancer
100%
clinical trials
11%
combined therapy
17%
communities
20%
coronaviruses
17%
correlations
17%
covid-19
34%
data
17%
diseases
29%
failures
18%
fatty acids
17%
hepatocytes
9%
hepatomas
17%
hospitals
35%
immunotherapy
17%
implementation
17%
indonesia
22%
induction
17%
irradiation
17%
levels
36%
liver
24%
management
17%
medicine
8%
metastases
9%
muscles
17%
navigation
17%
neoplasms
8%
organoids
17%
patients
92%
phenobarbital
17%
plasma
17%
plasma cells
17%
precision
17%
radiations
36%
radiotherapy
62%
rectum
17%
resources
19%
reviews
40%
risks
8%
safety
17%
surgery
18%
sustainability
17%
swine
17%
therapy
21%
tumors
12%
weight
8%
workers
17%
Keyphrases
Asia
17%
Breast Cancer
19%
Breast Cancer Management
17%
Cancer Epidemiology
17%
Cancer Genomics
17%
Cancer Immunotherapy
17%
Cancer Patients
25%
Cancer Registry Data
17%
Cancer Treatment
24%
Complete Response
22%
COVID-19 Pandemic
51%
Diethylnitrosamine
17%
Domestic Swine
17%
Engineered Organoids
17%
Ensuring Safety
17%
Evidence-based Review
17%
Extramedullary Plasmacytoma
17%
Genomic Big Data
17%
Genomic Data
17%
Handgrip
17%
Healthcare Workers
17%
Hepatocellular Carcinoma
17%
Hepatocytes
17%
Hospital-based Cancer Registry
17%
Humanized Liver
17%
In Cancer
22%
Indonesia
44%
Indonesian
17%
Intensity-modulated Radiotherapy
17%
International Atomic Energy Agency
17%
Irradiation
17%
Liver Failure
17%
Low-middle Income Countries
17%
Meta-analysis
17%
Paediatric Exposure
17%
Patient Navigation Program
17%
Patient Navigator
17%
Phenobarbital
17%
Precision Oncology
17%
Radiation Oncology
31%
Radiation Quality
17%
Radiation Therapy
17%
Radiotherapy
51%
Radiotherapy Services
17%
Rapid Advancement
17%
Referral Hospital
21%
Regional Cooperation
17%
Resource-constrained
17%
Stress Level
17%
Vulva
17%
Medicine and Dentistry
Bioartificial Liver
5%
Breast Cancer
19%
Cancer
7%
Cancer Cell Line
17%
Cancer Epidemiology
17%
Cancer Registry
17%
Cancer Therapy
5%
Chemoradiotherapy
17%
Clinical Trial
11%
Contralateral
5%
COVID-19
51%
Disease Free Survival
5%
End Stage Liver Disease
17%
Health Care
17%
Hepatocyte
17%
Immunity
8%
Immunocompetent Cell
8%
Intensity Modulated Radiation Therapy
17%
Liver Failure
5%
Liver Transplantation
8%
Low and Middle Income Countries
17%
Malignant Neoplasm
57%
Medical Oncology
8%
Meta-Analysis
17%
Metastatic Carcinoma
8%
Neoadjuvant Therapy
11%
Neoplasm
22%
Observational Study
11%
Oncology
25%
Organoid
17%
Overall Survival
5%
Patient Care
18%
Patient Referral
19%
Pediatrics
17%
Personalized Medicine
8%
Plasmacytoma
17%
Potential Barrier
5%
Radiation Oncology
45%
Radiation Therapy
55%
Rectum Cancer
17%
Recurrence Risk
11%
Recurrent Disease
5%
Salvage Therapy
5%
Stereotactic Radiosurgery
17%
Systematic Review
5%
The Cancer Genome Atlas
8%
Tomotherapy
17%
Vestibular Schwannoma
17%
Volumetric Modulated Arc Therapy
17%
Vulva
17%
